Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update Lead value drivers are 100% ownership of NCX 470 and NCX 4251 in the U.S . 21 C sufficient for the Company to meet its current requirements for the next twelve months July 16, 2021 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, provided business and financial highlights for Q2 2021 for Nicox SA and its subsidiaries (the "Nicox Group") as well as an update on its strategy and key expected value-inflection milestone...